Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
Markus Axelsson(Sahlgrenska University Hospital), Jan Lycke(Sahlgrenska University Hospital), Staffan Nilsson(Chalmers University of Technology), Lars Rosengren(Sahlgrenska University Hospital), Clas Malmeström(University of Gothenburg), Sara Haghighi(Sahlgrenska University Hospital)
Cited by 192
Related Papers
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554
Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF
|Journal of Neurochemistry|1996|502
General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke
|Stroke|2017|471
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
|Neuroscience Letters|2001|452